• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在瑞典,若受药物影响驾车,对于管制药品血液中浓度限制为零。

Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances.

作者信息

Jones Alan Wayne

机构信息

Department of Forensic Toxicology, University Hospital, Linköping, Sweden.

出版信息

Traffic Inj Prev. 2005 Dec;6(4):317-22. doi: 10.1080/15389580500253760.

DOI:10.1080/15389580500253760
PMID:16266940
Abstract

OBJECTIVE

This article describes the background and implementation in Sweden of zero-concentration limits for controlled drugs in the blood of drivers. Eliminating the need to prove that a person's ability to drive safely was impaired by drugs has greatly simplified the prosecution case, which now rests primarily on the forensic toxicology report. Driving under the influence of a prescription drug listed as a controlled substance is exempt from the zero-limit law provided the medication was being used in accordance with a physician's direction and the person was not considered unfit to drive.

METHODS

The prevalence of driving under the influence of drugs (DUID) in Sweden was evaluated from police reports with the main focus on the toxicological findings. A large case series of DUID suspects was compared before and after introducing zero concentration limits in blood for controlled substances on July 1, 1999. The spectrum of drugs used by typical offenders and the concentrations of various licit and illicit substances in blood were evaluated and compared.

RESULTS

Immediately after the zero-limit law came into force, the number of cases of DUID submitted by the police for toxicological analysis increased sharply and is currently ten-fold higher than before the new legislation. Statistics show that about 85% of all blood samples sent for toxicological analysis have one or more banned substances present. Amphetamine is by far the leading drug of abuse in Sweden and was identified in about 50-60% of all DUID suspects either alone or together with other controlled substances. The next most frequently encountered illicit drug was tetrahydrocannabinol (THC), with positive findings in about 20-25% of cases. Various prescription drugs, mainly sedative-hypnotics like diazepam and flunitrazepam, were also highly prevalent and these occurred mostly together with illicit substances. Opiates, such as 6-acetyl morphine and morphine, the metabolites of heroin, were high on the list of substances identified. Most DUID suspects in Sweden were men (85%) who were poly-drug users combining illicit substances, like amphetamine and/or cannabis, with a prescription medication such as various benzodiazepines.

CONCLUSIONS

Sweden's zero-concentration limit has done nothing to reduce DUID or deter the typical offender because recidivism is high in this population of individuals (40-50%). Indeed, many traffic delinquents in Sweden are criminal elements in society with previous convictions for drunk and/or drugged driving as well as other offenses. The spectrum of drugs identified in blood samples from DUID suspects has not changed much since the zero-limit law was introduced.

摘要

目的

本文介绍了瑞典对驾驶员血液中管制药物实行零浓度限制的背景及实施情况。无需证明一个人的安全驾驶能力因药物而受损,这极大地简化了检控案件,目前该案件主要依据法医毒理学报告。若按照医生指示使用处方药且该人不被认为不适宜驾驶,则使用列为管制物质的处方药驾驶可免于零限制法律。

方法

通过警方报告评估瑞典药物影响下驾驶(DUID)的流行情况,主要关注毒理学结果。对1999年7月1日对管制物质实行血液零浓度限制前后的大量DUID嫌疑人案例系列进行比较。评估并比较典型违法者使用的药物种类以及血液中各种合法和非法物质的浓度。

结果

零限制法律生效后,警方提交进行毒理学分析的DUID案件数量急剧增加,目前比新立法前高出十倍。统计数据显示,送去进行毒理学分析的所有血液样本中约85%含有一种或多种违禁物质。在瑞典,苯丙胺是迄今为止最主要的滥用药物,在所有DUID嫌疑人中,约50 - 60%的人单独或与其他管制物质一起被检测出含有该物质。接下来最常遇到的非法药物是四氢大麻酚(THC),约20 - 25%的案例检测呈阳性。各种处方药,主要是像地西泮和氟硝西泮这样的镇静催眠药,也非常普遍,且大多与非法物质一起出现。阿片类药物,如6 - 乙酰吗啡和吗啡(海洛因的代谢物),在检测出的物质清单中排名靠前。瑞典大多数DUID嫌疑人是男性(85%),他们是多药使用者,将苯丙胺和/或大麻等非法物质与各种苯二氮䓬类等处方药混合使用。

结论

瑞典的零浓度限制对减少DUID或威慑典型违法者毫无作用,因为这群人的累犯率很高(40 - 50%)。事实上,瑞典许多交通违法者是社会中的犯罪分子,之前有过酒后和/或吸毒驾驶以及其他犯罪的定罪记录。自实行零限制法律以来,从DUID嫌疑人血液样本中检测出的药物种类变化不大。

相似文献

1
Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances.在瑞典,若受药物影响驾车,对于管制药品血液中浓度限制为零。
Traffic Inj Prev. 2005 Dec;6(4):317-22. doi: 10.1080/15389580500253760.
2
Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results.受损驾驶员血液中处方药的浓度:结果解读的考量因素
Ther Drug Monit. 2007 Apr;29(2):248-60. doi: 10.1097/FTD.0b013e31803d3c04.
3
Predominance of illicit drugs and poly-drug use among drug-impaired drivers in Sweden.瑞典药物影响下驾驶者中非法药物及多药滥用的主导情况。
Traffic Inj Prev. 2007 Dec;8(4):361-7. doi: 10.1080/15389580701329344.
4
The frequency of drugs among Danish drivers before and after the introduction of fixed concentration limits.丹麦在引入固定浓度限制前后司机吸毒的频率。
Traffic Inj Prev. 2010 Aug;11(4):329-33. doi: 10.1080/15389581003792783.
5
Five-year update on the occurrence of alcohol and other drugs in blood samples from drivers killed in road-traffic crashes in Sweden.瑞典道路交通事故中死亡司机血液样本中酒精及其他药物出现情况的五年期更新报告。
Forensic Sci Int. 2009 Apr 15;186(1-3):56-62. doi: 10.1016/j.forsciint.2009.01.014. Epub 2009 Feb 18.
6
Drugs and driving: the Finnish perspective.药物与驾驶:芬兰视角
Bull Narc. 2005;57(1-2):213-29.
7
First nationwide study on driving under the influence of drugs in Switzerland.瑞士首次全国范围内的药物影响下驾驶研究。
Forensic Sci Int. 2010 May 20;198(1-3):11-6. doi: 10.1016/j.forsciint.2010.02.014. Epub 2010 Mar 7.
8
Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment.被捕司机血液中苯丙胺浓度的年龄和性别差异:与损伤临床证据无关。
Addiction. 2007 Jul;102(7):1085-91. doi: 10.1111/j.1360-0443.2007.01802.x. Epub 2007 May 11.
9
What non-alcohol drugs are used by drinking drivers in Sweden? Toxicological results from ten years of forensic blood samples.瑞典的酒后驾车者使用哪些非酒精类药物?十年法医血液样本的毒理学结果。
J Safety Res. 2012 Jul;43(3):151-6. doi: 10.1016/j.jsr.2012.05.002. Epub 2012 Jun 1.
10
High concentrations of diazepam and nordiazepam in blood of impaired drivers: association with age, gender and spectrum of other drugs present.受损驾驶员血液中高浓度的地西泮和去甲地西泮:与年龄、性别及其他并存药物种类的关联。
Forensic Sci Int. 2004 Nov 10;146(1):1-7. doi: 10.1016/j.forsciint.2004.05.020.

引用本文的文献

1
Effectiveness of road safety interventions: An evidence and gap map.道路安全干预措施的有效性:证据与差距图。
Campbell Syst Rev. 2024 Jan 3;20(1):e1367. doi: 10.1002/cl2.1367. eCollection 2024 Mar.
2
Potentially Driver-Impairing Medications: Risks and Strategies for Injury Prevention.可能影响驾驶员的药物:预防伤害的风险与策略
Am J Lifestyle Med. 2016 Jan 13;10(1):17-20. doi: 10.1177/1559827615609050. eCollection 2016 Jan-Feb.
3
Effects of d-amphetamine on simulated driving performance before and after sleep deprivation.
**d-**苯丙胺对睡眠剥夺前后模拟驾驶表现的影响。
Psychopharmacology (Berl). 2012 Aug;222(3):401-11. doi: 10.1007/s00213-012-2744-7. Epub 2012 May 26.
4
The relationship between benzodiazepine use and traffic accidents: A systematic literature review.苯二氮䓬类药物使用与交通事故的关系:系统文献回顾。
CNS Drugs. 2010 Aug;24(8):639-53. doi: 10.2165/11533170-000000000-00000.
5
Driving under the influence of gamma-hydroxybutyrate (GHB).在γ-羟基丁酸(GHB)影响下驾驶。
Forensic Sci Med Pathol. 2008;4(4):205-11. doi: 10.1007/s12024-008-9040-1. Epub 2008 May 14.
6
Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.取代苯丙胺类药物的神经毒性:分子与细胞机制
Neurotox Res. 2007 Apr;11(3-4):183-202. doi: 10.1007/BF03033567.